Maryland-based Novavax phase 3 clinical trial expands to include children 12 to 17,

Participants in the study will be monitored for two years after the last injection. Advertisement. Phase 3 clinical trials are the last and longest steps of …, Participants in the study will be monitored for two years after the last injection. Advertisement. Phase 3 clinical trials are the last and longest steps of …, Read More

Scroll to Top